xRapid

About:

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Twitter/X: XrapidG

Top Investors: Charles-Edouard Bouee

Description:

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea.

Total Funding Amount:

$600000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Aix-en-provence, Provence-Alpes-Cote d'Azur, France

Founded Date:

2015-01-01

Contact Email:

info(AT)xrapid-group.com

Founders:

David Mendels, Jean Viry-Babel

Number of Employees:

1-10

Last Funding Date:

2016-09-01

IPO Status:

Private

Industries: